At the Center for Digestive Health, our providers are actively involved in clinical research to identify new gastrointestinal (GI) disease treatments. Our team publishes and presents original research each year in hundreds of papers and at regional, national and international conferences. We advance digestive disease care by evaluating the safety and efficacy of new medications and devices.
Our clinical research scientists partner with the world-renowned Benaroya Research Institute to conduct our national clinical trials and research studies. Through this longstanding partnership, we give hope to patients and their families. We study benign conditions like diverticulitis as well as groundbreaking new therapies for cancer treatment.
Our providers will explain your options and provide exceptional care at every step if you qualify for a clinical trial. Learn more about current colorectal clinical trials and liver, pancreas and biliary clinical trials.
Our research team has years of experience in protocol management, study implementation and digestive disease study coordination. We prepare and submit Institutional Review Board applications, protocols, consent forms and other regulatory documents.
The Center for Digestive Health offers annual research grants to attending physicians, residents and fellows (MD, PHD, ARNP, PA). If you treat digestive diseases, you are eligible for a grant, regardless of your department or specialty.
Researchers at the Center for Digestive Health have full access to our leading-edge facilities that offer:
Our research team includes senior clinical research coordinators certified through the Association of Clinical Research Professionals. Every member of our staff is Ethics and Good Clinical Practice certified.
Our staff experience ranges from six months to more than 10 years. The average time on our team is four to five years.
We’re proud to be leaders in digestive health research. On average, we start and complete more than 20 studies each year. Our experience includes:
Contact us to learn more about our current trials and opportunities for collaboration.